Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Description FOXO4-DRI is a D-retro-inverso research peptide derived from a FOXO4 interaction motif, used in controlled in-vitro studies of proteinprotein interactions, cellular senescence pathways, and peptide structureactivity relationships under non-clinical laboratory conditions
The studys participants did not have diabetes and did not take medication to manage their blood sugar
Consultation with a healthcare provider is crucial before starting this treatment
Once you have worked your way up to your maintenance dose, you remain on it for the remaining duration of your treatment
Novo Nordisk uses recombinant DNA technology with engineered Saccharomyces cerevisiae (yeast) to produce the peptide backbone, followed by chemical modification to attach the fatty acid sidechain
Mutations and damage to mitochondrial DNA can affect the function of oxidative phosphorylation complexes, leading to increased ROS generation
.png)
US$ 26.12
US$ 21.14
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
US$ 20.39
